盘龙药业股价涨5.06%，汇添富基金旗下1只基金位居十大流通股东，持有34.25万股浮盈赚取54.11万元

Group 1 - The core viewpoint of the news is that Panlong Pharmaceutical experienced a stock price increase of 5.06%, reaching 32.79 CNY per share, with a total market capitalization of 3.485 billion CNY [1] - Panlong Pharmaceutical, established on September 22, 1997, is located in Xi'an, Shaanxi Province, and was listed on November 16, 2017. The company specializes in the research, production, and sales of traditional Chinese medicine [1] - The main business revenue composition of Panlong Pharmaceutical includes 55.50% from self-produced traditional Chinese medicine, 22.42% from pharmaceutical distribution, 21.42% from traditional Chinese medicine pieces, and 0.52% from other sources [1] Group 2 - Among the top circulating shareholders of Panlong Pharmaceutical, a fund under Huatai PineBridge has reduced its holdings by 36,500 shares, now holding 342,500 shares, which accounts for 0.46% of the circulating shares [2] - The Huatai Zhongzheng Traditional Chinese Medicine ETF (560080) was established on September 26, 2022, with a current scale of 1.814 billion CNY. It has achieved a return of 1.14% this year, ranking 4129 out of 4222 in its category [2] - The fund has a one-year return of 20.45%, ranking 3665 out of 3804, and a cumulative return of 10.4% since its inception [2]